FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34673911000001102: Zonisamide 50mg capsules (Aristo Pharma GmbH) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105064901000001115 Zonisamide 50mg capsules (Aristo Pharma GmbH) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111607301000001118 Zonisamide 50mg capsules (Aristo Pharma Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zonisamide 50mg capsules (Aristo Pharma GmbH) Is a Product containing precisely zonisamide 50 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has active ingredient Zonisamide false Inferred relationship Existential restriction modifier 1
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has basis of strength substance Zonisamide true Inferred relationship Existential restriction modifier 1
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier 1
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has presentation strength denominator unit Capsule true Inferred relationship Existential restriction modifier 1
Zonisamide 50mg capsules (Aristo Pharma GmbH) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zonisamide 50mg capsules (Aristo Pharma GmbH) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has specific active ingredient Zonisamide true Inferred relationship Existential restriction modifier
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Zonisamide 50mg capsules (Aristo Pharma GmbH) Has excipient Polyoxyl castor oil false Inferred relationship Existential restriction modifier
Zonisamide 50mg capsules (Aristo Pharma GmbH) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zonisamide 50mg capsules (Aristo Pharma GmbH) 56 capsule 4 x 14 capsules Has AMP True Zonisamide 50mg capsules (Aristo Pharma GmbH) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start